pre-IPO PHARMA

COMPANY OVERVIEW

Casebia combines CRISPR/Cas9 expertise and technology from CRISPR Therapeutics with access to deep disease-state knowledge and protein engineering capabilities from Bayer. Our aim: to transform the lives of patients and families affected by genetic disease.


LOCATION

  • San Francisco, CA, USA

  • THERAPEUTIC AREAS

  • Autoimmune Disease
  • Hematology
  • Ophthalmology

  • WEBSITE

    https://casebia.com/


    CAREER WEBSITE

    https://casebia.com/join-us/#open-positions


    SOCIAL MEDIA


    INVESTORS

    bayer crispr-therapeutics


    PRESS RELEASES


    Oct 21, 2019

    CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics


    Jul 8, 2019

    Casebia Highlights Novel Research in Gene Editing Therapeutics for Hemophilia A


    Jun 4, 2019

    Casebia Announces Appointment of New SVP, Head of Technical Operations


    Apr 24, 2019

    Casebia Advances Genetic Engineering with New Tools and Techniques


    Apr 24, 2019

    Casebia Advances Genetic Engineering with New Tools and Techniques


    For More Press Releases


    Google Analytics Alternative